November 2023
1. WEISS J, Gibbons K, Ehyaee V, Perez-Silos V, et al
   Specific Polo-like kinase 1 (PLK1) expression in Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) suggests an intact immune surveillance program.
   Am J Pathol. 2023 Nov 1:S0002-9440(23)00415-7. doi: 10.1016/j.ajpath.2023.
   

   >> Share

   
   September 2023
2. JAFFE ES
   Evolution of Lymphoma Diagnosis in the Era of Personalized Medicine - A Marriage of Pathology and Genomics for Clinical Practice.
   Am J Pathol. 2023 Sep 19:S0002-9440(23)00323.
   

   >> Share

   
   May 2023
3. MONTESINOS-RONGEN M, Sanchez-Ruiz M, Siebert S, Winter C, et al
   AMD3100-mediated CXCR4 inhibition impairs development of primary lymphoma of the central nervous system.
   Am J Pathol. 2023 May 15:S0002-9440(23)00163.
   

   >> Share

   
   September 2022
4. CHUANG WY, Yu WH, Lee YC, Zhang QY, et al
   Deep Learning-Based Nuclear Morphometry Reveals an Independent Prognostic Factor in Mantle Cell Lymphoma.
   Am J Pathol. 2022 Sep 20. pii: S0002-9440(22)00282.
   

   >> Share

   
   May 2022
5. ZHANG Q, Wang HY, Nayak A, Nunez-Cruz S, et al
   Induction of Transcriptional Inhibitor Hairy and Enhancer of Split Homolog-1 and the Related Repression of Tumor-Suppressor Thioredoxin-Interacting Protein Are Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase Nucleophosm
   Am J Pathol. 2022 May 28. pii: S0002-9440(22)00148.
   

   >> Share

   
   June 2021
6. MATSUMOTO T, Oda Y, Hasegawa Y, Hashimura M, et al
   Anaplastic lymphoma kinase (ALK) overexpression is associated with aggressive phenotypic characteristics of ovarian high-grade serous carcinoma.
   Am J Pathol. 2021 Jun 29. pii: S0002-9440(21)00301.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share